Zhangzhou Pientzehuang Pharmaceutical reported CNY1.78B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 21.7M 4.09M Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Dianthus Therapeutics USD 761K 298K Jun/2026
Ionis Pharmaceuticals USD 243M 25M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Jiangsu Hengrui CNY 8.95B 320M Sep/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Moderna USD 1.31M 98.69M Sep/2026
Revvity USD 729M 680K Sep/2026
Sh Fosun Pharma CNY 10.07B 50M Dec/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.75B 10M Sep/2026
Wuxi Apptec CNY 12.6B 4.04B Dec/2026
Xeris Pharmaceuticals USD 92.1M 8.97M Jun/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026